Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Immaculada Margarit

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Infection|September 8, 2024
Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI studyFlorens Lohrmann, Androulla Efstratiou, Uffe B Skov Sørensen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2015
Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changesAnthony R Flores, Jessica Galloway-Peña, Pranoti Sahasrabhojane, et al.
NPJ Vaccines|January 25, 2024
Author Correction: Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particlesFilippo Carboni, Roberta Cozzi, Giacomo Romagnoli, et al.
NPJ Vaccines|October 6, 2023
Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particlesFilippo Carboni, Roberta Cozzi, Giacomo Romagnoli, et al.
Molecular & Cellular Proteomics : MCP|January 31, 2012
Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus caseGiuliano Bensi, Marirosa Mora, Giovanna Tuscano, et al.
Vaccine|September 28, 2010
Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidateAnna Kabanova, Immaculada Margarit, Francesco Berti, et al.
Science (New York, N.Y.)|July 5, 2005
Identification of a universal Group B streptococcus vaccine by multiple genome screenDomenico Maione, Immaculada Margarit, Cira D Rinaudo, et al.
European Child & Adolescent Psychiatry|July 9, 2018
European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescentsAnette Schrag, Davide Martino, Alan Apter, et al.
Nature Communications|August 5, 2014
Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracyclineViolette Da Cunha, Mark R Davies, Pierre-Emmanuel Douarre, et al.
Nature Communications|January 29, 2015
Corrigendum: Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracyclineViolette Da Cunha, Mark R Davies, Pierre-Emmanuel Douarre, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Infection|September 8, 2024
Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI studyFlorens Lohrmann, Androulla Efstratiou, Uffe B Skov Sørensen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2015
Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changesAnthony R Flores, Jessica Galloway-Peña, Pranoti Sahasrabhojane, et al.
NPJ Vaccines|January 25, 2024
Author Correction: Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particlesFilippo Carboni, Roberta Cozzi, Giacomo Romagnoli, et al.
NPJ Vaccines|October 6, 2023
Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particlesFilippo Carboni, Roberta Cozzi, Giacomo Romagnoli, et al.
Molecular & Cellular Proteomics : MCP|January 31, 2012
Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus caseGiuliano Bensi, Marirosa Mora, Giovanna Tuscano, et al.
Vaccine|September 28, 2010
Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidateAnna Kabanova, Immaculada Margarit, Francesco Berti, et al.
Science (New York, N.Y.)|July 5, 2005
Identification of a universal Group B streptococcus vaccine by multiple genome screenDomenico Maione, Immaculada Margarit, Cira D Rinaudo, et al.
European Child & Adolescent Psychiatry|July 9, 2018
European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescentsAnette Schrag, Davide Martino, Alan Apter, et al.
Nature Communications|August 5, 2014
Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracyclineViolette Da Cunha, Mark R Davies, Pierre-Emmanuel Douarre, et al.
Nature Communications|January 29, 2015
Corrigendum: Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracyclineViolette Da Cunha, Mark R Davies, Pierre-Emmanuel Douarre, et al.
Pageof 9